V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20218627 | 20083336 | 1.58 | 82 | Palliative (P) | 2017-09-28 | 2017-10-01 | HCX | null | N | HCX | 100738722 |
| 20218634 | 20083338 | null | null | null | 2016-07-04 | 2016-07-04 | ECarboX | 02 | null | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 101831473 |
| 20218636 | 20083339 | null | 81 | Palliative (P) | 2018-11-06 | 2018-11-10 | HCX | null | N | CAPECITABINE + IRINOTECAN | 101220733 |
| 20218637 | 20083340 | 1.78 | 73 | Palliative (P) | null | 2018-06-18 | null | null | N | CETUXIMAB + IRINOTECAN + MDG | 100752696 |
| 20218638 | 20083341 | null | null | null | null | 2020-06-29 | null | null | null | LENVATINIB | 101423774 |
| 20218644 | 20083344 | null | null | null | null | 2017-05-23 | null | null | null | HCX | 100275505 |
| 20218649 | 20083345 | 1.69 | 83 | Palliative (P) | 2020-03-08 | 2020-03-10 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | N | HCX | 100631581 |
| 20218658 | 20083347 | 1.73 | 76 | Palliative (P) | null | 2016-05-14 | null | null | N | CETUXIMAB + IRINOTECAN + MDG | 101733966 |
| 20218659 | 20083348 | null | null | null | null | 2020-02-28 | null | null | null | CISPLATIN + ETOPOSIDE | 100254143 |
| 20218662 | 20083349 | 1.52 | 100 | Neo-adjuvant (N) | null | 2018-02-14 | null | null | N | CISPLATIN + EPIRUBICIN + FLUOROURACIL | 101802823 |
| 20218664 | 20083351 | null | null | null | 2016-10-31 | 2016-11-28 | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 02 | null | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 100249676 |
| 20218670 | 20083352 | null | null | null | 2017-10-23 | 2017-10-29 | null | null | null | CISPLATIN + EPIRUBICIN + FLUOROURACIL | 100408035 |
| 20218680 | 20083354 | 1.8 | 72.5 | Palliative (P) | 2017-10-18 | 2017-10-21 | ECarboX | 02 | N | CETUXIMAB + IRINOTECAN + MDG | 100736566 |
| 20218683 | 20083355 | null | null | null | 2018-02-19 | 2018-03-18 | null | null | null | CISPLATIN + ETOPOSIDE | 100795550 |
| 20218684 | 20083356 | null | null | null | 2017-11-24 | 2017-12-05 | CISPLATIN + ETOPOSIDE | 02 | null | CISPLATIN + ETOPOSIDE | 100230445 |
| 20218688 | 20083357 | 1.64 | 48.3 | Palliative (P) | 2018-05-02 | 2018-05-05 | Cape+Cisplatin+Trastuzumab Load | 02 | N | HCX | 100648573 |
| 20218689 | 20083358 | null | 88.2 | null | 2017-10-16 | 2017-10-16 | LENVATINIB | 02 | Y | LENVATINIB | 100750950 |
| 20218700 | 20083359 | 0 | 51 | Palliative (P) | 2020-01-25 | 2020-01-31 | null | null | N | CETUXIMAB + IRINOTECAN + MDG | 100729761 |
| 20218701 | 20083360 | 1.8 | 50.35 | Palliative (P) | 2017-08-09 | 2017-08-18 | LENVATINIB | 02 | N | LENVATINIB | 100462821 |
| 20218703 | 20083361 | null | null | null | null | 2016-05-19 | null | null | null | CAPECITABINE + MITOMYCIN + RT | 101169018 |
| 20218704 | 20083362 | 1.87 | 0 | Palliative (P) | null | 2019-11-15 | null | null | null | CAPECITABINE + IRINOTECAN | 101562882 |
| 20218705 | 20083363 | null | 58.7 | Neo-adjuvant (N) | 2018-07-22 | 2018-08-03 | null | null | N | CISPLATIN + EPIRUBICIN + FLUOROURACIL | 100653318 |
| 20218706 | 20083364 | 1.64 | 38.4 | Adjuvant (A) | null | 2017-04-13 | null | null | N | CETUXIMAB + IRINOTECAN + MDG | 101857138 |
| 20218708 | 20083366 | 1.91 | 80.2 | null | null | 2018-12-19 | null | null | N | CAPECITABINE + MITOMYCIN + RT | 100782090 |
| 20218711 | 20083367 | 1.7 | 63 | Neo-adjuvant (N) | 2016-07-13 | 2016-07-20 | ECF | 02 | null | CISPLATIN + EPIRUBICIN + FLUOROURACIL | 101720830 |
| 20218712 | 20083368 | 1.64 | 67.1 | Palliative (P) | null | 2017-03-27 | null | null | Y | HCX | 100341192 |
| 20218713 | 20083369 | 1.73 | 71 | Neo-adjuvant (N) | 2016-05-26 | 2016-06-15 | null | null | null | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 100637272 |
| 20218718 | 20083371 | null | 81.2 | Palliative (P) | null | 2017-05-26 | null | null | N | CAPECITABINE + MITOMYCIN + RT | 100249492 |
| 20218748 | 20083375 | 1.73 | 93.1 | Palliative (P) | null | 2018-05-13 | null | null | N | CETUXIMAB + IRINOTECAN + MDG | 101340308 |
| 20218749 | 20083376 | 1.59 | 77.9 | Palliative (P) | 2021-11-28 | 2021-11-29 | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | null | N | CETUXIMAB + IRINOTECAN + MDG | 100457586 |
| 20218752 | 20083378 | 1.62 | null | Palliative (P) | 2017-11-01 | 2017-11-05 | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | null | N | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 100753860 |
| 20218756 | 20083379 | null | null | null | null | 2016-07-10 | null | null | null | CAPECITABINE + IRINOTECAN | 101326076 |
| 20218757 | 20083380 | null | null | null | null | 2017-07-05 | null | null | null | CETUXIMAB + IRINOTECAN + MDG | 100522493 |
| 20218766 | 20083382 | 1.76 | 76 | Palliative (P) | 2019-04-10 | 2019-04-18 | null | null | null | HCX | 100492274 |
| 20218773 | 20083383 | null | null | null | null | null | null | null | null | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 100722399 |
| 20218774 | 20083384 | null | null | null | 2018-03-29 | 2018-04-06 | CAPECITABINE + MITOMYCIN + RT | N | null | CAPECITABINE + MITOMYCIN + RT | 101325161 |
| 20218777 | 20083386 | 1.68 | 94.9 | Palliative (P) | null | 2019-10-30 | null | null | N | CAPECITABINE + MITOMYCIN + RT | 100220257 |
| 20218779 | 20083387 | 1.65 | 48 | Palliative (P) | 2016-12-10 | 2016-12-15 | null | null | null | CISPLATIN + ETOPOSIDE | 101439985 |
| 20218782 | 20083388 | 1.64 | null | 03 | 2019-11-24 | 2019-12-01 | CAPECITABINE + IRINOTECAN | N | N | CAPECITABINE + IRINOTECAN | 101291531 |
| 20218787 | 20083390 | 1.69 | 66.25 | null | 2020-01-18 | 2020-02-15 | CAPECITABINE + MITOMYCIN + RT | 02 | N | CAPECITABINE + MITOMYCIN + RT | 100237092 |
| 20218788 | 20083391 | null | 80.9 | null | null | 2016-11-07 | null | null | null | LENVATINIB | 100517509 |
| 20218792 | 20083392 | 1.62 | 72.2 | Palliative (P) | null | 2020-01-12 | null | null | N | HCX | 101067445 |
| 20218793 | 20083393 | 1.61 | 60.9 | Adjuvant (A) | 2019-04-17 | 2019-05-11 | null | null | N | CAPECITABINE + MITOMYCIN + RT | 101440901 |
| 20218801 | 20083394 | null | null | null | null | 2018-04-24 | null | null | null | CAPECITABINE + MITOMYCIN + RT | 101749725 |
| 20218802 | 20083395 | null | null | null | 2019-12-18 | 2020-01-07 | null | null | null | HCX | 100406692 |
| 20218807 | 20083396 | 1.71 | 89.5 | Curative (C) | null | 2016-07-24 | null | null | Y | CAPECITABINE + MITOMYCIN + RT | 100772723 |
| 20218808 | 20083397 | 1.77 | 71 | Palliative (P) | null | 2019-12-05 | null | null | N | CISPLATIN + ETOPOSIDE | 100172881 |
| 20218809 | 20083398 | null | null | null | 2016-04-11 | 2016-04-11 | ECarboX | null | null | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 100700624 |
| 20218813 | 20083399 | null | null | null | 2016-08-20 | 2016-09-11 | null | null | null | CAPECITABINE + MITOMYCIN + RT | 100426277 |
| 20218816 | 20083401 | 1.63 | 75.9 | null | null | 2016-03-27 | null | null | null | CAPECITABINE + IRINOTECAN | 101098703 |